Form 8-K - Current report:
SEC Accession No. 0001999480-24-000025
Filing Date
2024-07-29
Accepted
2024-07-29 16:19:04
Documents
15
Period of Report
2024-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alto-20240724.htm   iXBRL 8-K 33759
2 EX-10.1 exhibit101.htm EX-10.1 286427
  Complete submission text file 0001999480-24-000025.txt   529506

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20240724.xsd EX-101.SCH 2182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alto-20240724_def.xml EX-101.DEF 13376
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20240724_lab.xml EX-101.LAB 26944
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20240724_pre.xml EX-101.PRE 15941
17 EXTRACTED XBRL INSTANCE DOCUMENT alto-20240724_htm.xml XML 3752
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 241152627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)